Delivery Order SPE2DB22D3010-SPE2DB25FP3AP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Envarsus XR 1 mg tablets (30-count units) valued at $1,035.60. This non-competitive delivery order, which will be completed by June 24, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,151.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packaging) with a ceiling value of $1,227.78. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on November 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,288.86. This competitively awarded, firm fixed-price delivery order is set to be completed by September 8, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single delivery order issued under a larger contract vehicle rather than a standalone...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Envarsus XR 4 mg tablets (100-count packages) valued at $1,711.94. This firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive standing as a federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Envarsus XR 4 mg tablets (100 count) with a contract value of $1,711.95. This firm fixed price delivery order is scheduled for completion by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Envarsus XR 1 mg tablets (100-count) at a ceiling value of $2,577.72. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) valued at $3,608.26. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is scheduled for completion by December 4, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Envarsus XR 1 mg tablets (30-count package) with a ceiling value of $1,165.05. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. The contract is scheduled for ultimate completion by September 18,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a ceiling value of $1,711.95. This firm fixed-price delivery order is scheduled for completion by October 7, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's established capability to...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB25FP3APDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a ceiling value of $6,847.80. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for ultimate completion by August 13, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. That prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The current delivery order reflects the company's established role as a critical pharmaceutical distributor for federal medical procurement, particularly serving Defense Health Agency and other military healthcare systems through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 7/23/25 |